advertisement
Giannoulis DA 63
Showing records 1 to 25 | Display all abstracts from Giannoulis DA127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Li Z
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Stuart KV; de Vries VA
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Chng WL
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
de Vries VA; de Vries VA; de Vries VA
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Liu Z
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Schuster AK
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Do T
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Yu Y
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Nakano M
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
van der Heide FCT
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Chen LJ
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Delcourt C
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Loo Y; Loo Y
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Cougnard-Grégoire A
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Chan ASY
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Schweitzer C; Brandl C
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Topouzis F; Nongpiur ME
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Zimmermann ME
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Ozaki M
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Heid IM; Farinha C
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Nakano S
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Coimbra R
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Kubota T; Perera SA
Nature communications 2025; 16: 7620
127149 Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium
Luben RN; Hayat S
Ophthalmology 2025; 132: 1114-1124
127117 Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Husain R
Nature communications 2025; 16: 7620
